What is Xeris Biopharma Holdings Inc Annual Revenue?

Xeris Biopharma Holdings Inc Annual Revenue rose 23.89%, in the last year to $203.07 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Xeris Biopharma Holdings Inc Annual Net Profit?

Xeris Biopharma Holdings Inc Annual Net Profit rose 11.92% in the last year to $54.84 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Xeris Biopharma Holdings Inc Price to Earning Ratio?

Xeris Biopharma Holdings Inc Price to Earning Ratio is -17.34, which is negative.

What is Xeris Biopharma Holdings Inc Stock Price?

Xeris Biopharma Holdings Inc Stock Price rose 141.58% and outperformed its sector by 132.72% in the past year.

What is Xeris Biopharma Holdings Inc Quarterly Revenue?

Xeris Biopharma Holdings Inc Quarterly Revenue rose 47.94% YoY to $60.12 M. Its sector's average revenue growth YoY for the quarter was 3.1%.

What is Xeris Biopharma Holdings Inc Quarterly Net profit?

Xeris Biopharma Holdings Inc Quarterly Net profit rose 51.42% YoY to $9.22 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Xeris Biopharma Holdings Inc Mutual Fund Holding?

Xeris Biopharma Holdings Inc Mutual Fund Holding increased by 2.4% in the last quarter to 26.51.

What is Xeris Biopharma Holdings Inc Promoter Share Holding?

Xeris Biopharma Holdings Inc Promoter Share Holding increased by 1.32% in the most recent quarter to 33.73%.

What is Xeris Biopharma Holdings Inc Interest Coverage Ratio?

Xeris Biopharma Holdings Inc Interest Coverage Ratio is -0.87, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Xeris Biopharma Holdings Inc Institutional Holding?

Xeris Biopharma Holdings Inc Institutional Holding increased by 2.65% in the last quarter to 43.32.

Xeris Biopharma Holdings Inc XNAS: XERS

Xeris Biopharma Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Xeris Biopharma Holdings Inc: Is Infosys Ltd. worth buying?
Item: Xeris Biopharma Holdings Inc
Rating: 2.03100
Author: Trendlyne DVM scores

about

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrom...

4.88 0.09 (1.88%)

162.37% Gain from 52W Low

1.8M XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

10.0 / 100

Technically Bullish

71.2 / 100

6

1Yr Price target upside is 32%

6 analysts

Xeris Biopharma Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xeris Biopharma Holdings Inc FAQ

How is Xeris Biopharma Holdings Inc today?

Xeris Biopharma Holdings Inc today is trading in the green, and is up by 1.88% at 4.88.

How has Xeris Biopharma Holdings Inc performed historically?

Xeris Biopharma Holdings Inc is currently trading up 1.88% on an intraday basis. In the past week the stock fell -2.59%. stock has been up 35.93% in the past quarter and rose 141.58% in the past year. You can view this in the overview section.